Home / PEX11A Knockout Cell Lines

PEX11A Knockout Cell Lines

Gene: PEX11A

Official Full Name: peroxisomal biogenesis factor 11 alphaprovided by HGNC

Gene Summary: This gene is a member of the PEX11 family, which is composed of membrane elongation factors involved in regulation of peroxisome maintenance and proliferation. This gene product interacts with peroxisomal membrane protein 19 and may respond to outside stimuli to increase peroxisome abundance. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Oct 2012]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO33851 PEX11A Knockout cell line (HeLa) Human PEX11A 1:3~1:6 Negative Online Inquiry
KO33852 PEX11A Knockout cell line (HCT 116) Human PEX11A 1:2~1:4 Negative Online Inquiry
KO33853 PEX11A Knockout cell line (HEK293) Human PEX11A 1:3~1:6 Negative Online Inquiry
KO33854 PEX11A Knockout cell line (A549) Human PEX11A 1:3~1:4 Negative Online Inquiry

Background

PEX11A Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of peroxisomal biogenesis and function. These cell lines have been engineered to lack the PEX11A gene, which encodes a protein critical for the proliferation of peroxisomes—organelles responsible for various metabolic processes, including fatty acid oxidation and reactive species detoxification. By providing a definitive model in which PEX11A is absent, researchers can investigate the downstream effects on peroxisomal integrity and metabolism, thus elucidating the gene's role in cellular physiology.

The key function of PEX11A Gene Knockout Cell Lines stems from their ability to mimic pathological states associated with impaired peroxisomal function. Mechanistically, these cell lines enable scientists to explore how the absence of PEX11A influences peroxisome number, morphology, and the efficiency of metabolic pathways reliant on peroxisomes. This framework is crucial for understanding diseases such as Zellweger syndrome and other peroxisome biogenesis disorders, which are characterized by severe metabolic dysfunctions due to compromised peroxisomal activity.

In clinical research and drug development settings, PEX11A Gene Knockout Cell Lines serve as invaluable tools for screening potential therapeutics aimed at restoring peroxisomal function. Their specific design allows for high-throughput screening of compounds that may influence peroxisome dynamics, thus accelerating the identification of novel treatments for metabolic disorders.

Unique selling points of these cell lines include their robust genetic validation, ease of use in various types of assays, and compatibility with advanced imaging techniques. Compared to traditional cell lines, which may have uncharacterized or variable peroxisomal functions, PEX11A knockout models offer a controlled environment with guaranteed knockout efficiency, enhancing reproducibility in experimental results.

For researchers and clinicians focused on metabolic diseases and peroxisome-related functions, the value of PEX11A Gene Knockout Cell Lines lies in their ability to provide clear insights into the complexities of peroxisomal biology. They facilitate a deeper understanding of metabolic diseases, ultimately contributing to the advancement of therapeutic strategies aimed at treating such conditions.

With a commitment to innovation and scientific excellence, our company specializes in developing high-quality biological products, including cell lines that empower researchers to make significant breakthroughs in cell and molecular biology.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.